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Abstract
Background: Malnutrition and inflammation are common and serious complications in patients with acute kidney 
injury (AKI). However, the profile of these complications in patients with AKI caused by crush syndrome (CS) remains 
unclear. This study describes the clinical characteristics of malnutrition and inflammation in patients with AKI and CS 
due to the Wenchuan earthquake.
Methods: One thousand and twelve victims and eighteen healthy adults were recruited to the study. They were 
divided into five groups: Group A was composed of victims without CS and AKI (904 cases); Group B was composed of 
patients with CS and AKI who haven't received renal replacement therapy (RRT) (57 cases); and Group C was 
composed of patients with CS and AKI receiving RRT (25 cases); Group D was composed of earthquake victims with AKI 
but without CS (26 cases); and Group E was composed of 18 healthy adult controls. The C-reactive protein (CRP), 
prealbumin, transferrin, interleukin-6 and TNF-α were measured and compared between Group E and 18 patients from 
Group C.
Results: The results indicate that participants in Group C had the highest level of serum creatinine, blood urea nitrogen 
and uric acid. Approximately 92% of patients with CS who had RRT were suffering from hypoalbuminemia. The 
interleukin-6 and CRP levels were significantly higher in patients with CS AKI receiving RRT than in the control group. 
Patients in Group C received the highest dosages of albumin, plasma or red blood cell transfusions. One patient in 
Group C died during treatment.
Conclusions: Malnutrition and inflammation was common in patients with earthquake-related CS and had a negative 
impact on the prognosis of these subjects. The results of this study indicate that the use of RRT, intensive nutritional 
supplementation and transfusion alleviated the degree of malnutrition and inflammation in hemodialysis patients with 
crush syndrome.
Background
Acute renal failure, which is now referred to as acute kid-
ney injury (AKI) [1], is a significant clinical problem that
has an independent and major negative impact on patient
outcomes [1-3]. Up to 5% of patients with AKI in inten-
sive care units (ICU) may require renal replacement ther-
apy (RRT) [3], and AKI has been demonstrated to be a
major independent risk factor for mortality in patients
with critical illnesses [4,5]. In specific cases of patients
with AKI, nutritional status has been found to be closely
related to the rates of comorbidities and mortality [6-10].
A recent report also demonstrated that serum prealbu-
min levels of less than 11 mg/dL were associated inde-
pendently with a higher risk of death [11]. Nutritional
depletion and protein consumption has also been found
to influence the effectiveness of treatment and worsen
the prognosis of patients with AKI [7,9,10].
Until now, the characteristics of malnutrition in
patients with AKI caused by crush syndrome (CS) have
remained unclear. Since CS accelerates catabolism, which
would theoretically aggravate malnutrition, this is an
important issue. AKI and CS caused by earthquakes usu-
ally result in far worse clinical outcomes because of the
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Page 2 of 6severe complications that typically ensue [12-14]. Previ-
ous reports reveal that CS and subsequent AKI is the
main cause of death following an earthquake [12,13]. Fur-
thermore, AKI results not only in fundamental alterations
to metabolism, but also in the activation of a pro-oxida-
tive and proinflammatory state [7,15]. Many inflamma-
tory biomarkers are activated in patients with AKI and
these would further aggravate the malnutrition of such
patients [7,15]. It is therefore vital to determine the char-
acteristics of malnutrition and inflammation in patients
with AKI that resulted from earthquake-related CS.
In this article, the characteristics of malnutrition and
inflammation in participants with CS and AKI following
the Wenchuan earthquake are summarized. The effects
of RRT on the status malnutrition and inflammation of
participants are also investigated.
Methods
During the Wenchuan earthquake, the Sichuan Academy
of Medical Sciences and Sichuan Provincial People's Hos-
pital was one of the closest hospitals to the epicenter and,
as a result, many patients with injuries due to trauma
were admitted to the hospital immediately after the
earthquake.
One thousand and twelve victims and eighteen healthy
adults were recruited to the study. They were divided into
five groups: Group A was composed of victims without
CS and AKI (904 cases); Group B was composed of
patients with CS and AKI who haven't received renal
replacement therapy (RRT) (57 cases); and Group C was
composed of patients with CS and AKI receiving RRT (25
cases); Group D was composed of earthquake victims
with AKI but without CS (26 cases); and Group E was
composed of 18 healthy adult controls.
Serum total protein and serum albumin levels were
compared between these three groups during the first
three days of their admission. The serum C-reactive pro-
tein (CRP), prealbumin, and transferrin levels were mea-
sured in participants in Group C and Group E.
Interleukin 6 (IL-6) (Wuhan Boster Biological Technol-
ogy, China) and tumor necrosis factor-α (TNF-α)
(Wuhan Boster Biological Technology, China) levels were
tested by enzyme-linked immunosorbent assay (ELISA)
methods in accordance with the specifications of the
manufacturers in Group E and in 18 participants from
Group C who received RRT and were followed for more
than 14 days. The serum samples of these patients were
collected on the first day and the forteenth day of RRT.
The clinical parameters (included blood pressure,
hemoglobin, blood urea nitrogen, and serum creatinine
levels, total serum protein, serum albumin, serum elec-
trolytes, etc. All of them were detected on the admission
day) of these patients were also compared. We also
recorded the dosages of infused albumin, plasma, or red
blood cell in three groups. All of the patients with CS and
AKI were given nutritional supports by intravenous infu-
sion and/or oral supplements. The modalities of RRT in
Group C included intermittent hemodialysis (IHD) (7
cases), continuous veno-venous hemofiltration (CVVH)
(11 cases), and modality from IHD to CVVH (8 cases).
For the purpose of this study, CS was diagnosed on the
basis of the presence of swollen limbs and history of limb
compression according to the criteria described previ-
ously [16,17]. AKI was defined as an abrupt (within 48
hours) reduction in kidney function, which is defined
currently as an absolute increase in serum creatinine of
more than or equal to 0.3 mg/dl (≥26.4 μmol/l), a per-
centage increase in serum creatinine of more than or
equal to 50% (1.5-fold from baseline), or a reduction in
urine output (documented oliguria of less than 0.5 ml/kg
per hour for more than six hours) [1]. AKI was classified
into three stages following the AKIN criteria [1].
These clinical data were collated and checked by
another physician. Statistical analysis was conducted
using SPSS version 13.0 (SSPS Inc, Chicago, IL, USA).
The protocol for this study was approved by medical
ethics committee of the Sichuan Academy of Medical Sci-
ences and Sichuan Provincial People's Hospital, and
informed written consent for the study was obtained
from all of the patients with RRT or healthy adults. For
the other patients without AKI, this study was an audit of
historical data without any interventions, and therefore,
the chairman of the hospital medical ethics committee
confirmed that formal ethical approval was not required.
Results
The clinical characteristics of the victims with or without 
acute kidney injury
The clinical characteristics among Group A, B and C
were compared. The results revealed that the participants
with CS and AKI had significantly increased the levels of
BUN, serum creatinine, plasma glucose, uric acid, serum
potassium, serum phosphorus, aspartate aminotrans-
ferase (AST), serum lactate dehydrogenase (LDH) and
creatinine kinase (CK). On the other hand, the hemoglo-
bin, bicarbonate, and calcium levels had decreased signif-
icantly. All of these abnormalities were more prominent
in CS and AKI patients with RRT (Table 1). One partici-
pant in Group C died because of severe sepsis.
The serum total protein and albumin levels were found
to have significantly decreased in participants who were
treated by RRT. The mean serum albumin was only 22.0 ±
8.5 g/L (range: 8.8-49.3 g/L) in Group C participants. In
Group B participants, 57.9% (33/57) patients had an albu-
min level of less than 35 g/L. The proportion was 92.0%
(23/25). Moreover, 16 patients (64.0%) had an albumin
level of less than 25 g/L in the participants of Group C.
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crush syndrome
To clarify the clnical manifetations of AKI patients with
CS, We compared the renal function, plasma total pro-
tein, and albumin levels between participants in Group B
and in Group D. The participants with AKI and CS were
older and had significantly higher levels of BUN, serum
creatinine, serum potassium. However, the serum cal-
cium, total plasma protein, and albumin levels were sig-
nificantly lower in these patients than those without CS
(Table 2).
The inflammation markers and the effect of RRT
The markers of inflammation (CRP, prealbumin, transfer-
rin, IL-6, and TNF-α) were detected in 18 healthy con-
trols and in 18 participants from Group C who received
RRT and were followed for more than 14 days. The par-
ticipants with CS and AKI had significantly higher serum
levels of IL-6 and CRP than the normal controls. The
serum levels of prealbumin and transferrin decreased sig-
nificantly in these patients (Table 3). After 14 days of
RRT, the serum levels of IL-6 and TNF-α were 756.5 ±
288.0 ng/ml and 40.8 ± 16.0 ng/ml, respectively, and these
did not change significantly from the pre-treatment lev-
els.
RRT influenced markers of inflammation and nutrition
During the period of treatment, providing transfusions of
albumin, plasma, or red blood cells was one of the most
effective methods of treatment. The supplements used in
the different groups are displayed in Table 4. Participants
in Group C received the most dosages of albumin, plasma
and red blood cells.
Discussion
It has been reported that malnutrition is common in
patients with AKI and that nutritional status is closely
related to the outcomes of these patients [6-10]. In partic-
ular, malnutrition has often been found to result in
increased the mortality among these patients [6-10]. A
previous report revealed that the mortality in acute renal
failure patients with severe malnutrition was significantly







Age (mean years ± SD) 46.2 ± 24.4 55.6 ± 22.2* 36.1 ± 16.4*#
Male (%) 50.3 45.6 52.0
Mean arterial pressure 
(mmHg)
90.9 ± 12.3 92.2 ± 13.7 89.8 ± 15.1
White blood cells (×109/L) 8.01 ± 3.81 9.25 ± 4.36 11.12 ± 6.00*
Hemoglobin (g/L) 107.8 ± 26.5 103.7 ± 30.6 87.2 ± 31.4**#
Platelet (×109/L) 175.3 ± 95.2 128.4 ± 45.7** 104.8 ± 69.5**
Blood urea nitrogen (mmol/L) 6.05 ± 3.83 12.19 ± 6.65** 22.90 ± 10.62**##
Serum creatinine (μmol/L) 80.4 ± 63.6 163.2 ± 73.6** 419.1 ± 141.5**##
Glucose (mmol/L) 5.86 ± 2.36 7.07 ± 4.10** 7.33 ± 4.66**
Uric acid (μmol/L 233.9 ± 113.5 348.0 ± 234.5* 486.1 ± 230.2**##
Potassium (mmol/L) 3.93 ± 0. 51 4.12 ± 0.80 5.80 ± 1.27**##
HCO3 -(mmol/L) 25.4 ± 3.8 24.0 ± 5.3* 20.1 ± 5.9**##
Calcium (mmol/L) 2.20 ± 0.22 2.08 ± 0.32** 1.71 ± 0.25**##
Phosphorus (mmol/L) 1.13 ± 0.42 1.31 ± 0.56 1.74 ± 0.76**
Total protein (g/L) 60.8 ± 9.3 57.8 ± 11.4 43.5 ± 11.5**##
Albumin (g/L) 34.6 ± 6.5 32.3 ± 7.0 22.0 ± 8.5**##
Aspartate aminotransferase 
(U/L)
38(28, 59) 52(35, 309)* 768(336, 1213)**##
Serum lactate dehydrogenase 
(U/L)
307(214, 541) 615(318, 1157)* 5451(2532, 9964)**##
Creatinkinase (U/L) 166 (75, 731) 216 (116,1017) 18636(7585, 23852)**##
Group A, victims without crush syndrome (CS) and acute kidney injury (AKI); Group B, patients with CS and AKI haven't received renal 
replacement therapy (RRT); Group C, patients with CS and AKI have received RRT. Compared to Group A, *:p < 0.05, **:p < 0.01; Compared to 
Group B, #:p < 0.05, ##: p < 0.01.
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129 vs. 24/130) [6]. However, the nutritional problems in
patients with CS and AKI has remained unclear and the
only prior description of this problem did not include
detailed data [18]. This study reported the clinical charac-
teristics of malnutrition and inflammation in patients
with earthquake-related CS and AKI. The results demon-
strated that malnutrition was a common complication in
patients with CS and AKI and was also typically more
severe in patients with CS and AKI who received RRT.
Recently, the International Society of Renal Nutrition
and Metabolism (ISRNM) convened an expert panel to
review and develop standard terminologies and defini-
tions related to wasting, cachexia, malnutrition, and
inflammation in chronic kidney disease and AKI. The
ISRNM expert panel recommends the term 'protein-
energy wasting' for loss of body protein mass and fuel
reserves [19]. Decreased serum albumin is the main diag-
nostic indicator of malnutrition in patients with AKI.
However, nutritional status evaluation in this clinical
condition is difficult because most of the traditional
nutritional tools (e.g. body weight and body mass index,
anthropometric measurements, and serum protein levels)
are often misleading, owing to the presence of acute ill-
ness and/or of alterations in body water distribution and
external fluid balance derangements [10,19]. In this study,
it was found that the serum total protein and albumin
levels decreased significantly in CS and AKI participants
without RRT and was much lower still in CS and AKI
participants with RRT. In the participants with CS and
AKI who were treated by RRT, the mean level of serum
albumin was only 22.0 g/L and 92% of these participants
had decreased serum albumin of less than 35 g/L. These
participants also had higher levels of AST, LDH, CK, and
creatinine. Compared to those participants with AKI but
without CS, the participants with both CS and AKI had
lower levels of total protein and albumin. These results






Age 41.5 ± 19.0 67.4 ± 18.9 1.6 × 10-7
Male(%) 50.0 42.3 0.516
Hemoglobin (g/L) 98.5 ± 33.7 98.7 ± 26.6 0.979
Blood urea nitrogen (mmol/L) 17.33 ± 10.27 11.37 ± 5.46 1.0 × 10-3
Serum creatinine (μmol/L 280.0 ± 169.2 157.7 ± 57.9 6.8 × 10-6
Uric acid (μmol/L 391.1 ± 248.8 393.1 ± 224.3 0.975
Potassium (mmol/L) 5.04 ± 1.26 3.79 ± 0. 59 4.56 × 10-8
Calcium (mmol/L) 1.88 ± 0.30 2.10 ± 0.38 0.015
Phosphorus (mmol/L) 1.52 ± 0.68 1.33 ± 0.62 0.283
Total protein(g/L) 50.6 ± 12.8 60.6 ± 11.2 1.3 × 10-3
Albumin (g/L) 27.1 ± 9.1 33.6 ± 6.2 3.7 × 10-4
Group B, AKI patients with CS; Group D, AKI patients without CS





Age 42.8 ± 15.3 42.1 ± 20.3
Male (%) 44.4 55.6
CRP(mg/L) 5.1 ± 2.6 107.7 ± 61.2**
Prealbumin (mg/L) 368.2 ± 42.5 200.0 ± 58.8**
Transferrin (ng/L) 2.76 ± 0.65 1.02 ± 0.48*
IL-6 (ng/mL) 334.3 ± 117.2 882.7 ± 306.8**
TNF-α (ng/ml) 39.5 ± 10.1 42.3 ± 16. 9
a18 participants from Group C who received RRT and were followed for more than 14 days.*p < 0.05, **p < 0.01.
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tion status of earthquake victims.
Multiple factors could explain the observed malnutri-
tion in these participants. These include anorexia,
impaired protein metabolism and transport, oxidative
stress, production of nonspecific inflammatory cytok-
ines, resistance to insulin, volume overload, metabolic
acidosis, nutrient losses through the hemodiafilter, and
patient comorbidities [7,10,19]. This indicates that AKI,
which results in the loss of lean body mass, may not be
primarily related to reduced nutrient intake. In partici-
pants with both CS and AKI, the malnutrition resulted
from not only above-mentioned causes, but also from
exudation and bleeding related to injuries sustained dur-
ing the earthquake. These participants also demonstrated
prominent inflammation, which may have contributed to
their malnutrition. In our study, the serum levels of IL-6
and CRP increased significantly and the serum levels of
prealbumin and transferrin decreased significantly in the
CS and AKI participants who were treated with RRT. Fur-
thermore, the IL-6 did not decrease after RRT for 14 days.
This indicates that the mechanisms of inflammation con-
tinued to exacerbate the malnutrition of these patients by
accelerating catabolism and inhibiting anabolism. The
data presented herein demonstrates that the inflamma-
tory process in the participants with CS and AKI was
severe.
Therefore, in patients with AKI, a close investigation
between nutritional support and RRT is required, espe-
cially when highly efficient RRTs, such as CVVH, or daily
prolonged intermittent RRT, such as sustained low-effi-
ciency dialysis (SLED), are used [7,10,19,20]. Adequate
nutritional support is necessary to maintain protein
stores and to correct pre-existing or disease-related defi-
cits in the lean body mass. CS patients with AKI follow-
ing an earthquake, especially those treated with RRT, are
at more risk of nutritional depletion than other critically
ill patients. The results presented here indicate that
patients with CS and AKI require specific nutritional
support involving the supplementation of albumin,
plasma and red blood cells, all of which are main treat-
ments for patients with CS and AKI following an earth-
quake. In our study, participants with CS and AKI who
were treated by RRT received the highest dosages of albu-
min, plasma and red blood cells. Only one patient died
because of severe sepsis. These results suggest that nutri-
tional support is one of the most important treatments
for the patients with AKI resulting from CS, especially in
those patients who were treated by RRT.
Conclusions
Malnutrition and inflammation was common in patients
with earthquake-related crush syndrome and acute kid-
ney injury. These patients had more obvious hypopro-
teinemia, hypoalbuminemia, and anemia. They also had
higher levels of inflammation markers and needed more
nutritional supplements. The results of this study indicate
that the use of RRT, intensive nutritional supplementa-
tion and transfusion could alleviate the degree of malnu-
trition and inflammation in patients with crush
syndrome and acute kidney injury after massive earth-
quake.
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